The Egyptian Journal of Neurology, Psychiatry and Neurosurgery

Table 1 Baseline demographic data and clinical characteristics of PD patients

From: Baseline predictors of progression of Parkinson’s disease in a sample of Egyptian patients: clinical and biochemical

	Mean (SD)/frequency (%)	Range
Age (years)	56.45 (9.31)	32–78
Gender
Male	34 (75.6%)
Female	11 (24.4%)
AOO (years)	51.32 (9.67)	26–74
DOI (years)	4.90 (3.1)	0.25–14
MDS-UPDRS Total score OFF	81.75 (33.02)	29–176
MDS-UPDRS-I	15.25 (7.29)	1–35
MDS-UPDRS-II	18.48 (10.19)	0–44
MDS-UPDRS-III OFF	47.89 (19.82)	13–101
Hoehn and Yahr OFF	2.53 (0.69)	1.5–4
Schwab and England ADL OFF	76.14 (13.16)	30–90
TUG OFF	19.21 (16.31)	7.86–82.80
(10-MWT) Comfortable speed OFF (m/s)	0.77 (0.33)	0.10–1.29
(10-MWT) Maximum speed OFF (m/s)	1.031 (0.43)	0.12–1.75
BBS OFF	45.77 (9.91)	14–56
NFOG-Q OFF	10.57 (10.10)	0–29
IPAQ	2058.77 (821.20)	636–3942
MMSE	26.45 (3.17)	16–30
NMSS total score	61.57 (44.19)	4–205
BDI	17.61 (9.87)	0–51
PDQ-39	37.08 (18.68)	2.6–76.7

AOO age of onset, DOI duration of illness, MDS-UPDRS Movement Disorder Society—Unified Parkinson’s Disease Rating Scale, ADL activities of daily living, TUG Time Up and Go Test, 10-MWT 10-Meter Walking Test, BBS Berg Balance Scale, NFOG-Q New Freezing of Gait Questionnaire, IPAQ International Physical Activity Questionnaire, MMSE Mini-Mental State Examination, NMSS Non-Motor Symptoms Scale, BDI Beck Depression Inventory, PDQ_39 Parkinson’s Disease Questionnaire-39

Back to article page